Life sciences company Great Basin, which closed a $7.6m series D round featuring Hitachi Chemical in April, has raised more than $8m from its initial public offering.
Great Basin Scientific, a US-based life sciences company that counts electronics manufacturer Hitachi has one of its investors, has raised just over $8m in its initial public offering.
Great Basin commercialises technologies for the molecular diagnostic testing market. It sold 1.15 million shares priced at $7.00 each.
The proceeds will be used for sales and marketing, research and development, the development of new tests for Group B Strep, and to manufacture analysers it provides to customers free of charge.
The…
